acetylcysteine has been researched along with Mast Cell Activation Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Britti, D; Cordaro, M; Crupi, R; Cuzzocrea, S; Di Paola, R; Gugliandolo, E; Impellizzeri, D; Siracusa, R | 1 |
1 other study(ies) available for acetylcysteine and Mast Cell Activation Disease
| Article | Year |
|---|---|
N-acetyl-L-cysteine reduces Leishmania amazonensis-induced inflammation in BALB/c mice.
Topics: Acetylcysteine; Animals; Cytokines; Hyperalgesia; Inflammation; Leishmania mexicana; Leishmaniasis, Cutaneous; Male; Mastocytosis; Mice, Inbred BALB C; Oxidative Stress | 2020 |